Latest Commercialization News

Petratherm Limited's latest drilling at the Rosewood Heavy Mineral Sand Prospect confirms extensive, high-grade titanium mineralisation over at least 15 square kilometres, reinforcing the project's world-class potential.

Vitrafy Life Sciences reports strong progress in cryopreservation technology development and US market expansion following a successful $35 million IPO. The company highlights improved biological sample preservation outcomes and strategic commercial milestones.

Vitrafy Life Sciences reported a dramatic increase in half-year losses to $25.7 million, yet successfully raised $35 million through an IPO to fuel its cryopreservation technology expansion.

REA Group has delivered a robust first half FY25 performance, posting a 20% revenue increase and a 26% rise in net profit, underpinned by strong Australian and Indian market growth. The company also announced a 26% higher interim dividend, signaling confidence in its ongoing momentum.

Dreadnought Resources has raised $4.1 million to advance its Mangaroon Gold Project, including a strategic partnership with Black Cat Syndicate. The funding underpins a self-funded exploration strategy targeting high-grade gold production in Western Australia.

Thor Energy plc has appointed Andrew Hume as Managing Director, bringing a seasoned energy executive to spearhead its expansion into natural hydrogen exploration.

Centuria Office REIT has released its HY25 Property Compendium, revealing a robust $1.885 billion portfolio diversified across Australia with strong occupancy and sustainable credentials.

Centuria Office REIT reported solid HY25 results, delivering $34.7 million in Funds From Operations and maintaining strong portfolio occupancy. The REIT is actively transforming office space into data infrastructure, positioning itself for future growth amid a challenging office market.

VRX Silica Limited's Arrowsmith North silica sand project faces a formal appeal from the Conservation Council of WA, challenging the recent environmental approval recommendation. The company is preparing its response while continuing to advance parallel permitting processes.

KALINA Power has partnered with Crusoe to develop multiple AI data centres co-located with near-zero emissions natural gas power plants in Alberta, promising stable cash flows and sustainable energy solutions.

Neurizon Therapeutics has been granted a pivotal US patent for its lead drug candidate NUZ-001, extending protection until 2039 and enhancing its commercial and clinical positioning in neurodegenerative disease treatment.

A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.